Skip to main content

Table 1 General baseline characteristics of participants with and without T2DM

From: Introduction of the DiaGene study: clinical characteristics, pathophysiology and determinants of vascular complications of type 2 diabetes

 

Cases

Controls

P value

Number of participants

1886

854

 

Female sex, n (%)

874 (46.4)

511 (59.8)

<0.001

Age, year, median (IQR)

65.7 (58.5–72.9)

64.9 (60.4–69.4)

0.72

Age of onset diabetes, year, median (IQR)

55 (47–63)

N/A

N/A

Duration of diabetes, year, median (IQR)

8.1 (2.8–13.5)

N/A

N/A

BMI, kg/m2, median (IQR)

29.5 (26.4–32.7)

25.5 (23.3–27.7)

<0.001

HbA1c, mmol/mol, median (IQR)

50.8 (43.7–57.9)

37.7 (36.1–39.3)

<0.001

Diabetes treatment, % (n/n-available/n-missing)

 No glucose-lowering medication

19.2 (340/1772/114)

N/A

N/A

 Oral glucose-lowering agent

64.3 (1140/1773/113)

N/A

N/A

 Insulin

32.3 (572/1772/114)

N/A

N/A

Systolic blood pressure, mmHg, median (IQR)

140 (129–151)

137 (124–150)

<0.001

Diastolic blood pressure, mmHg, median (IQR)

78 (71–85)

82 (76–89)

<0.001

Total cholesterol, mmol/L, median (IQR)

4.2 (3.6–4.8)

5.6 (4.9–6.2)

<0.001

Triglycerides, mmol/L, median (IQR)

1.4 (0.9–2.0)

1.2 (0.9–1.5)

<0.001

HDL-cholesterol, mmol/L, median (IQR)

1.1 (0.9–1.3)

1.4 (1.2–1.6)

<0.001

LDL-cholesterol, mmol/L, median (IQR)

2.3 (1.8–2.8)

3.5 (2.9–4.1)

<0.001

Creatinine, µmol/L, median (IQR)

78 (66–91)

72 (63–81)

<0.001

eGFR < 60 mL/min, % (n/n-available/n-missing)

21.2 (372/1756/130)

5.0 (40/795/59)

<0.001

Cardiovascular disease, % (n/n-available/n-missing)

 Any macrovascular disease

38.0 (660/1738/148)

8.3 (68/824/30)

<0.001

 Ischemic heart disease

28.0 (497/1778/108)

4.9 (41/842/12)

<0.001

 Ischemic brain disease

12.0 (211/1757/129)

1.4 (12/840/14)

<0.001

 Peripheral arterial disease

10.8 (193/1783/103)

2.2 (18/823/31)

<0.001 

Microvascular diabetes complications, % (n/n-available/n-missing)

 Any microvascular disease

34.3 (561/1637/249)

N/A

N/A

 Diabetic retinopathy

17.3 (308/1778/108)

N/A

N/A

 Diabetic nephropathy

23.0 (387/1684/202)

N/A

N/A

Family history, % (n/n-available/n-missing)

 First-degree relative with T2DM

64.4 (1104/1714/172)

33.3 (269/809/45)

<0.001

 First-degree relative with CVD

68.3 (1086/1590/296)

68.7 (519/755/99)

0.87

 Any relative with early-onset CVD

45.0 (780/1732/154)

41.5 (342/825 29)

0.09

Descent

 Caucasian descent, % (n/n-available/n-missing)

91.9 (1613/1755)

96.1 (810/843/11)

<0.001

 Age of death father, year, median (IQR)

73 (65–82)

75 (67–84)

<0.001

 Age of death mother, year, median (IQR)

78 (70–86)

81 (73–89)

<0.001

  1. Table 1 shows baseline characteristics of participants from the DiaGene study
  2. BMI body mass index, CVD cardiovascular disease, eGFR estimated glomerular filtration rate calculated with the Modification of Diet in Renal Disease-formula, IQR interquartile range, n-total total number of participants for whom information was available, T2DM type 2 diabetes mellitus